French Biotech Launches Tech Platform to Boost New Cancer Treatment Research


Transgene has announced the launch of Invir.IO, a new platform to help the design of new oncolytic viruses that modulate the cancer microenvironment. Transgene designs targeted immunotherapies for the treatment of cancer and infectious diseases. Their lead products include Pexa-Vec, an oncolytic …

This awesome article French Biotech Launches Tech Platform to Boost New Cancer Treatment Research appeared first on Labiotech.eu. Be kind and don’t copy it without asking 😉



Source link

Read More

EU gives French Biotech €20M to Continue the Fight Against Antibiotic Resistance


Da Volterra has been boosted by a €20M loan to speed up the development of solutions for the antibiotic resistance crisis. The French biopharma concentrates on the prevention and treatment of serious infections. This is a big area of interest due …

This awesome article EU gives French Biotech €20M to Continue the Fight Against Antibiotic Resistance appeared first on Labiotech.eu. Be kind and don’t copy it without asking 😉



Source link

Read More